Study highlights postop transfusion risksEvidence mounts that liberal approach is no better than conservative, and may even increase morbidity and mortality Oral drugs may hold new hope for MS patientsEase of use is attractive, but questions remain over what longer-term use will show about side-effects Dabigatran lowers deep vein clot risk Newer drug compares well with warfarin and does not require lab monitoring Negation exemptions needed for focused-practice visits, says OMA head Caution eases over using antivirals for pandemic H1N1 Heart transplant alternative closer to reality Survival rates look promising for second-generation left ventricular assist devices, but numbers are still small Radial approach lessens kidney risk: B.C. study Doing cardiac catheterization through the wrist has advantages over femoral access, although it is more technically challenging Celebrating a doctor’s well-spent life Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Rural alternative clinic gets 11th hour reprieve First Previous 1613 1614 1615 1616 1617 Next Last
